|
ZNF740 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.017040E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.103800E-01 |
| Normal-vs-Stage2 |
2.258500E-02 |
| Normal-vs-Stage3 |
1.499490E-03 |
| Normal-vs-Stage4 |
1.972440E-02 |
| Stage1-vs-Stage2 |
9.324800E-03 |
| Stage1-vs-Stage3 |
5.94339999999693E-05 |
| Stage1-vs-Stage4 |
5.577100E-03 |
| Stage2-vs-Stage3 |
7.301800E-01 |
| Stage2-vs-Stage4 |
8.230600E-01 |
| Stage3-vs-Stage4 |
5.035600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.080300E-02 |
| Normal-vs-AfricanAmerican |
6.240800E-01 |
| Normal-vs-Asian |
4.894200E-02 |
| Caucasian-vs-AfricanAmerican |
4.682000E-01 |
| Caucasian-vs-Asian |
3.921900E-02 |
| AfricanAmerican-vs-Asian |
1.171400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.031770E-01 |
| Normal-vs-Female |
1.965790E-01 |
| Male-vs-Female |
7.755200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.454620E-01 |
| Normal-vs-Age(41-60Yrs) |
5.292000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.920200E-02 |
| Normal-vs-Age(81-100Yrs) |
5.670400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.248600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.530000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.502600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.390360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.123900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.384200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.384400E-03 |
| Normal-vs-Grade 2 |
7.347400E-01 |
| Normal-vs-Grade 3 |
6.364600E-03 |
| Normal-vs-Grade 4 |
1.157220E-04 |
| Grade 1-vs-Grade 2 |
3.064400E-02 |
| Grade 1-vs-Grade 3 |
1.420850E-04 |
| Grade 1-vs-Grade 4 |
1.9557999999531E-06 |
| Grade 2-vs-Grade 3 |
4.614100E-04 |
| Grade 2-vs-Grade 4 |
3.08569999996067E-06 |
| Grade 3-vs-Grade 4 |
8.072400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.613000E-01 |
| Normal-vs-ccB subtype |
1.799030E-03 |
| ccA subtype-vs-ccB subtype |
6.47799999999865E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.659800E-02 |
| Normal-vs-N1 |
3.008800E-01 |
| N0-vs-N1 |
9.112200E-01 |
|
|
